NCT05068583 Liquid Biopsies in Pediatric Solid Tumors
| NCT ID | NCT05068583 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital Los Angeles |
| Condition | Pediatric Solid Tumor, Unspecified, Protocol Specific |
| Study Type | OBSERVATIONAL |
| Enrollment | 320 participants |
| Start Date | 2019-05-08 |
| Primary Completion | 2029-05-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 320 participants in total. It began in 2019-05-08 with a primary completion date of 2029-05-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is being done to determine if traces of tumor can be found in the blood before, during, and after patients stop treatment. We will analyze the tumor material to see if it is similar to tumor tissue and if the tumor material in blood is helpful in monitoring the disease.
Eligibility Criteria
Inclusion Criteria: * Newly diagnosed, relapsed, or refractory histologically confirmed high grade bone or soft tissue sarcoma or malignant renal, thyroid, germ cell, or hepatic tumors, OR * Healthy individual with no history of cancer or chronic medical problems and \< 21 years of age Exclusion Criteria: * CNS Malignancies * Individuals \< 6 months of age
Contact & Investigator
Fariba Navid, MD
PRINCIPAL INVESTIGATOR
Children's Hospital Los Angeles
Frequently Asked Questions
Who can join the NCT05068583 clinical trial?
This trial is open to participants of all sexes, aged 6 Months or older, studying Pediatric Solid Tumor, Unspecified, Protocol Specific. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05068583 currently recruiting?
Yes, NCT05068583 is actively recruiting participants. Contact the research team at fnavid@chla.usc.edu for enrollment information.
Where is the NCT05068583 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT05068583 clinical trial?
NCT05068583 is sponsored by Children's Hospital Los Angeles. The principal investigator is Fariba Navid, MD at Children's Hospital Los Angeles. The trial plans to enroll 320 participants.